Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOCILIZUMAB Cause Intentional product use issue? 5,078 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5,078 reports of Intentional product use issue have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 5.2% of all adverse event reports for TOCILIZUMAB.

5,078
Reports of Intentional product use issue with TOCILIZUMAB
5.2%
of all TOCILIZUMAB reports
1,660
Deaths
2,018
Hospitalizations

How Dangerous Is Intentional product use issue From TOCILIZUMAB?

Of the 5,078 reports, 1,660 (32.7%) resulted in death, 2,018 (39.7%) required hospitalization, and 1,506 (29.7%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 5,078 reports have been filed with the FAERS database.

What Other Side Effects Does TOCILIZUMAB Cause?

Drug ineffective (32,342) Rheumatoid arthritis (20,652) Pain (18,384) Off label use (18,256) Arthralgia (15,536) Joint swelling (14,831) Fatigue (13,802) Rash (12,327) Drug intolerance (11,952) Contraindicated product administered (11,547)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280) HYDROXYCHLOROQUINE (3,059)

Which TOCILIZUMAB Alternatives Have Lower Intentional product use issue Risk?

TOCILIZUMAB vs TOCILIZUMAB-AAZG TOCILIZUMAB vs TOCOPHEROL TOCILIZUMAB vs TOFACITINIB TOCILIZUMAB vs TOFERSEN TOCILIZUMAB vs TOLNAFTATE

Related Pages

TOCILIZUMAB Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue TOCILIZUMAB Demographics